Cartalax — Khavinson bioregulator — cartilage / connective tissue
Cartalax targets cartilage and connective tissue. Proposed to restore chondrocyte gene expression programs, promote proteoglycan synthesis, reduce matrix metalloproteinase activity, and support joint health. Very limited published clinical data.
نظرة عامة
هذه الصفحة جزء من مكتبة المركّبات المُصنَّفة بالأدلة في Hormonaly. جميع الادعاءات السريرية مرتبطة بمصادر علمية مُحكَّمة عبر خط أنابيب التحقق المزدوج للاستشهادات.
فئة المركّب
Khavinson bioregulator — cartilage / connective tissue
آلية العمل
Cartalax targets cartilage and connective tissue. Proposed to restore chondrocyte gene expression programs, promote proteoglycan synthesis, reduce matrix metalloproteinase activity, and support joint health. Very limited published clinical data.
الوضع التنظيمي
Not FDA approved. Research peptide.
مستوى الأدلة
Very Low — limited published data. Evidence from Khavinson group only.